MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Celcuity Inc. - Common Stock (NQ:CELC)

104.51 -0.36 (-0.34%)
Streaming Delayed Price Updated: 4:00 PM EST, Feb 13, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 407,742
Open 105.05
Bid (Size) 103.00 (100)
Ask (Size) 107.00 (100)
Prev. Close 104.87
Today's Range 103.16 - 107.75
52wk Range 7.575 - 120.31
Shares Outstanding 46,271,259
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Soleus Adds a Significant Number of Celcuity Shares ↗
This clinical-stage biotech develops targeted cancer therapies and diagnostics using proprietary technology for personalized treatment. 
Via The Motley Fool
Director Sells 20,000 Celcuity Shares for $2.4 Million Following 933% Share Price Jump ↗
Focused on targeted cancer therapies, this biotech firm reported a notable insider sale amid a year of extraordinary stock performance. 
Via The Motley Fool
Topics Regulatory Compliance

Performance

YTD
+3.9%
+3.9%
1 Month
-0.7%
-0.7%
3 Month
+13.3%
+13.3%
6 Month
+102.7%
+102.7%
1 Year
+711.4%
+711.4%

More News

Read More
News headline image
The $170B Survival Race: Why Big Pharma is Snapping Up Late-Stage Cancer Tech
From Equity Insider
Via GlobeNewswire
News headline image
The Great Rotation: Small Caps Lead the Charge as 2026 Trading Opens
Via MarketMinute
Topics Artificial Intelligence ETFs Economy
Celcuity Stock Near All-Time Highs — And This Major Biotech Investor Is Still Jumping In ↗
Via The Motley Fool
News headline image
3 Stocks You’ll Wish You Bought Before 2026 ↗
Via MarketBeat
News headline image
This Fund Bought $38 Million of Celcuity as Stock Surges on Investigational Cancer Drug Results ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
This Fund Bought $38 Million of Celcuity as Stock Surges on Investigational Cancer Drug Results ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
GEO Shares Down 44% as Fund Sells $9 Million in Stock Amid ICE Allegations and Softer Outlook ↗
Via The Motley Fool
Topics Immigration Regulatory Compliance
News headline image
Earnings Scheduled For November 12, 2025 ↗
Via Benzinga
News headline image
Exploring Celcuity's Earnings Expectations ↗
Via Benzinga
News headline image
Celcuity Analyst No Longer Bullish Despite Breast Cancer Therapy Application ↗
Via Benzinga
News headline image
CELCUITY INC (NASDAQ:CELC) Stock Surges 70% in a Month Following Q3 Earnings Beat and Positive Clinical Data ↗
Via Chartmill
Topics Earnings
News headline image
Celcuity Eyeing Cancer Treatment Riddle. Stock Flys 534% This Year. ↗
Via Investor's Business Daily
News headline image
These stocks are moving in today's session ↗
Via Chartmill
News headline image
12 Health Care Stocks Moving In Monday's Intraday Session ↗
Via Benzinga
News headline image
Top movers analysis in the middle of the day on 2025-10-20: top gainers and losers in today's session. ↗
Via Chartmill
News headline image
Gapping stocks in Monday's session ↗
Via Chartmill
News headline image
WW International, Replimune Group, Datavault AI, GRAIL And Other Big Stocks Moving Higher On Monday ↗
Via Benzinga
Topics Artificial Intelligence
News headline image
Top 1% Celcuity Shoots To Record High On Roche-Rivaling Breast Cancer Results ↗
Via Investor's Business Daily
Topics Government
News headline image
Dow Jumps Over 200 Points; Cleveland-Cliffs Shares Jump After Q3 Results ↗
Via Benzinga
Topics Stocks
News headline image
These stocks are moving in today's pre-market session ↗
Via Chartmill
News headline image
12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
Via Benzinga
News headline image
Why Delcath Systems Shares Are Trading Higher By Over 14%; Here Are 20 Stocks Moving Premarket ↗
Via Benzinga
News headline image
Clinical Breakthroughs Converge as Immunotherapy Market Surges Past $136 Billion
Via FinancialNewsMedia

Frequently Asked Questions

Is Celcuity Inc. - Common Stock publicly traded?
Yes, Celcuity Inc. - Common Stock is publicly traded.
What exchange does Celcuity Inc. - Common Stock trade on?
Celcuity Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Celcuity Inc. - Common Stock?
The ticker symbol for Celcuity Inc. - Common Stock is CELC on the Nasdaq Stock Market
What is the current price of Celcuity Inc. - Common Stock?
The current price of Celcuity Inc. - Common Stock is 104.51
When was Celcuity Inc. - Common Stock last traded?
The last trade of Celcuity Inc. - Common Stock was at 02/13/26 04:00 PM ET
What is the market capitalization of Celcuity Inc. - Common Stock?
The market capitalization of Celcuity Inc. - Common Stock is 4.84B
How many shares of Celcuity Inc. - Common Stock are outstanding?
Celcuity Inc. - Common Stock has 5B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story